The European Union has released its long-awaited guidelines on cervical cancer screening and diagnosis. These recommendations mark a major step toward uniform and effective cancer prevention across member states.
Key take-home messages:
-
Cytology-based screening is recommended AGAINST – it may delay access to more effective HPV-based screening and is considered worse than no screening at all.
- Screening under age 30 is only advised if effective triage is available, such as extended HPV genotyping.
-
Screening beyond age 64 is not needed IF the woman has previously undergone HPV testing.
This represents a milestone in evidence-based policymaking and a push for higher-quality, cancer protection strategies in Europe.
Read more: here